Immutep (IMMP) Long-Term Debt Repayments (2016)

Immutep's (IMMP) quarterly Long-Term Debt Repayments came in at $97746.3 in Q2 2016.

Immutep (IMMP) Long-Term Debt Repayments (2016) Analysis & Trends

Immutep (IMMP) has 1 years of Long-Term Debt Repayments data on file, last reported at $97746.3 in Q2 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Repayments (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	17.05 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-10.01 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Immutep	56.46 Mn	-8.63 Mn	-	-

Download Data

Date	Value
Jun 30, 2016	97,746.33
Jun 30, 2016	97,746.33